A novel point mutation in CD18 causing the expression of dysfunctional CD11/CD18 leucocyte integrins in a patient with leucocyte adhesion deficiency (LAD)

Clinical and Experimental Immunology

Volumn 121, Issue 1, 2000, Pages 133-138

  Mathew, E C ^a   Shaw, J M ^a   Bonilla, F A ^b   Law, S K A ^a   Wright, D A ^c,d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c Emory Children's Center   (United States)

^d Valley Children's Hospital   (United States)

Author keywords

CD11 CD18; Integrin; Leucocyte adhesion deficiency

Indexed keywords

CD11 ANTIGEN; CD18 ANTIGEN; DNA FRAGMENT; INTEGRIN;

ALLELE; ANTIGEN EXPRESSION; ARTICLE; CASE REPORT; CELL STRAIN COS1; CELL SURFACE; FEMALE; FRAMESHIFT MUTATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HUMAN; LEUKOCYTE ADHERENCE; LEUKOCYTE ADHESION DEFICIENCY; LIGAND BINDING; MYCOSIS; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; WOUND HEALING;

ANIMALS; ANTIGENS, CD11; ANTIGENS, CD18; CHILD, PRESCHOOL; COS CELLS; FEMALE; HUMANS; LEUKOCYTE-ADHESION DEFICIENCY SYNDROME; MALE; POINT MUTATION;

EID: 0033945561     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01277.x     Document Type: Article

References (30)

1. Arnaout MA. Leukocyte adhesion molecules deficiency: its structural basis pathophysiology and implications for modulating the inflammatory response. Immunol Rev 1990; 114:145-80.
2. Anderson DC, Kishimoto TK, Smith CW. Leukocyte adhesion deficiency and other disorders of leukocyte adherence and motility. In: Shriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited diseases, 7th edn. New York: McGraw-Hill Inc., 1994:3955-94.
3. Kishimoto TK, Hollander N, Roberts TM, Anderson DC, Springer TA. Heterogeneous mutations in the β subunit common to the LFA-1, Mac-1, and p150,95 glycoproteins cause leukocyte adhesion deficiency. Cell 1987; 50:193-202.
4. Hogg N, Stewart MP, Scarth SL, Newton R, Shaw JM, Law SKA, Klein N. A novel leukocyte adhesion deficiency caused by expressed but nonfunctional β2 integrins Mac-1 and LFA-1. J Clin Invest 1999; 103:97-106.
5. Hildreth JEK, Gotch FM, Hildreth PDK, McMichael AJ. A human lymphocyte-associated antigen involved in cell mediated lympholysis. Eur J Immunol 1983; 12:202-8.
6. Uciechowski P, Schmidt RE. Cluster report: CD11. In: Knapp W, Dörken B, Gilks WR, Rieber EP, Schmidt RE, von Stein H, dem Borne AEGKr, eds. Leucocyte typing. IV White cell differentiation antigens. Oxford: Oxford University Press, 1989:543-51.
7. Andrew D, Shock A, Ortlepp S, Bell J, Robinson MK. KIM185, a monoclonal antibody to CD18 which induces a change in conformation of CD18 and promotes both LFA-1 and CR3-dependent adhesion. Eur J Immunol 1993; 23:2217-22.
8. Hogg N. CD11a workshop panel report. In: Kishimoto T, von Kikutani H, dem Borne A et al., eds. Leucocyte typing. VI White cell differentiation antigens. New York: Garland, 1997:355-7.
9. Dransfield I, Cabañas C, Craig A, Hogg N. Divalent cation regulation of the function of the leukocyte integrin LFA-1. J Cell Biol 1992; 116:219-26.
10. Simmons DL. Cloning cell surface molecules by transient expression in mammalian cells. In: Hartley D, ed. Cellular interactions in development. Oxford: Oxford University Press, 1993:93-128.
11. Wright AH, Douglass WA, Taylor GM, Lau YL, Higgins D, Davies KA, Law SKA. Molecular characterization of leukocyte adhesion deficiency in six patients. Eur J Immunol 1995; 25:717-22.
12. Bell GI, Karam JH, Rutter WJ. Polymorphic DNA region adjacent to the 5′ end of the human insulin gene. Proc Natl Acad Sci USA 1981; 78:5759-63.
13. 2+. Eur J Immunol 1998; 28:3291-300.
14. Back AL, Kerkering M, Baker D, Bauer TR, Embree LJ, Hickstein DD. A point mutation associated with leukocyte adhesion deficiency type 1 of moderate severity. Biochem Biophys Res Commun 1993; 193:912-8.
15. Weitzman JB, Wells CE, Wright AH, Clark PA, Law SKA. The gene organisation of the human β2 integrin subunit (CD18). FEBS Letters 1991; 294:97-103.
16. Kishimoto TK, O'Connor K, Lee A, Roberts TM, Springer TA. Cloning of the β subunit of the leukocyte adhesion proteins: homology to an extracellular matrix receptor defines a novel supergene family. Cell 1987; 48:681-90.
17. Law SKA, Gagnon J, Hildreth JEK, Wells CE, Willis AC, Wong AJ. The primary structure of the β-subunit of the cell surface adhesion glycoproteins LFA-1, CR3 and p150,95 and its relationship to the fibronectin receptor. EMBO J 1987; 6:915-9.
18. Douglass WA, Hyland RH, Buckley CD, Al-Shamkhani A, Shaw JM, Scarth SL, Simmons DL, Law SKA. The role of the cysteine-rich region of the β2 integrin subunit in the leukocyte function-associated antigen-1 (LFA-1, αLβ2, CD11a/CD18) heterodimer formation and ligand binding. FEBS Letters 1998; 440:414-8.
19. Goodman TG, Bajt ML. Identifying the putative metal ion-dependent adhesion site in the β2 (CD18) subunit required for αLβ2 and αMβ2 ligand interactions. J Biol Chem 1996; 271:23729-36.
20. Bailly P, Tontti E, Hermand P, Cartron JP, Gahmberg CG. The red cell LW blood group protein is an intercellular adhesion molecule which binds to CD11/CD18 leukocyte integrins. Eur J Immunol 1995; 25:3316-20.
21. Tian L, Yoshihara Y, Mizuno T, Mori K, Gahmberg CG. The neuronal glycoprotein telenchephalin is a cellular ligand for the CD11a/CD18 leukocyte integrin. J Immunol 1997; 158:928-36.
22. Gahmberg CG. Leukocyte adhesion: CD11/CD18 integrins and intercellular adhesion molecules. Current Opin Cell Biol 1997; 9:643-50.
23. Beller DI, Springer TA, Schreiber RD. Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor. J Exp Med 1982; 156:1000-9.
24. Wright SD, Weitz JI, Huang AJ, Levin SM, Silverstein SC, Loike JD. Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocyte recognizes fibrinogen. Proc Natl Acad Sci USA 1988; 85:7734-8.
25. Altieri DC, Edgington TS. The saturable high affinity association of factor X to ADP-stimulated monocytes defines a novel function of Mac-1 receptor. J Biol Chem 1988; 263:7007-15.
26. Diamond MS, Staunton DE, de Fougerolles AR, Stacker SA, Garcia-Aguilar J, Hibbs ML, Springer TA. ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18). J Cell Biol 1990; 111:3129-39.
27. Davis GE. The Mac-1 and p150,95 β2 integrins bind denatured proteins to mediate leukocyte cell-substrate adhesion. Exp Cell Res 1992; 200:242-52.
28. Thornton BP, Vetvicka V, Pitman M, Goldman RC, Ross GD. Analysis of the sugar specificity and molecular location of the β-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J Immunol 1996; 156:1235-46.
29. Coxon A, Rieu P, Barkalow FJ, Askari S, Sharpe AH, von Andrian UH, Arnaout MA, Mayadas TN. A novel role for the β2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. Immunity 1996; 5:653-66.
30. Law A. CR4. In: Morley BJ, Walport MJ, eds. The complement factsbook. London: Academic Press, 2000:198-203.